Stockreport

Vanda Pharmaceuticals Inc (VNDA) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising ... [Yahoo! Finance]

Vanda Pharmaceuticals Inc.  (VNDA) 
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm Check Earnings Report
PDF Hetlioz Net Product Sales (Q3 2024): $17.9 million, a 2% increase compared to Q3 2023. Ponvory Net Product Sales (Q3 2024): $5.9 million, a 32% decrease compared to Q [Read more]